About
CBRNE Industry Group
The Chemical, Biological, Radiological, Nuclear, and Explosive (CBRNE) Industry Group is a non-profit association composed of 130+ companies, not-for-profit organizations, and consultants who support national and international CBRNE defense activities. In addition to military defense against CBRNE weapons of mass destruction (WMD), the CBRNE Industry Group interests encompass domestic preparedness against WMDs, the Chemical Weapons Convention and other treaties. Member organizations also are actively involved in CBRNE programs that include destruction of WMDs around the world.
Officers
Tim Greenhaw, Chair
JRAD. COL Tim Greenhaw, USA, Ret, 30-year Army Chemical (CBRN) Officer, currently at Joint Research and Development Inc. as a Senior Program Manager with over a decade of experience in chemical and biological defense programs. His last active-duty assignment was at the Defense Threat Reduction Agency (DTRA) while serving as the Acting Director, Chemical & Biological Technologies Department. Prior to his assignment at DTRA Tim was selected for the Chief of Staff of the Army’s fellowship program with the Brookings Institution, and served as ambassador and strategic scout for senior Army leadership focused on enhancing strategic thinking, understanding and influencing policymaking at the national level. He previously served on the Joint Staff / J8 as Deputy Director for the Joint Requirements Office (JRO) for CBRND. Tim commanded the US Army Environmental Command, Fort Sam Houston, TX and served as the Deputy Director for Chemical and Biological Technologies Department at the Defense Threat Reduction Agency. He also commanded the Pueblo Chemical Depot (CO), with tactical and operational tours in Fort Bragg, Korea, and Hawaii. Deployments include OIF with MNC-I / 18th Airborne Corps. Education: BA- Environmental Policy from Bowling Green State University in 1992, Master of Science in Administration from Central Michigan University in 2004, and Master of Science in National Resource Strategy from the National Defense University in 2015.
​
James A. “Jim” Andrews, PhD Secretary
Dominion Science Initiatives Dr. James A. “Jim” Andrews is a scientist and federal R&D strategist with more than 25 years of experience supporting programs across the Chemical, Biological, Radiological, Nuclear, and Explosives (CBRNE) enterprise. His career spans leadership roles in the Department of Defense, federal regulatory agencies, industry, and consulting, with a consistent focus on advancing technologies that support national security, public health, and operational readiness. Dr. Andrews currently supports government, industry, and research organizations in navigating the federal CBRNE landscape, including opportunity shaping, proposal development, and alignment of technical capabilities with sponsor priorities. His work has supported efforts in chemical and biological detection, diagnostics, medical countermeasures, and emerging sensing technologies. Previously, at SRI International, he led business development and strategy across biosciences and CBRNE portfolios, supporting programs funded by organizations including DARPA, DTRA, BARDA, and JPEO-CBRND. His work included advancing technologies such as automated drug discovery platforms, next-generation diagnostics, medical devices, and trauma care solutions.
Dr. Andrews also served as Science Director and Director of Field Laboratory Operations for the Navy’s medical research enterprise, overseeing coordination across multiple laboratories in the United States and overseas. His leadership supported programs in infectious disease, biodefense, combat casualty care, and chemical and biological threat mitigation. Earlier, as an Assistant Navy Inspector General, he conducted inspections of public health, laboratory, and chemical/biological operations worldwide, providing oversight of mission-critical activities. He began his career conducting biomedical and biodefense research, including work in assay development, infectious disease surveillance, and vaccine-related studies, and later contributed to the FDA review of biologics and medical countermeasures. Dr. Andrews holds a PhD in Physiology and Biophysics from Georgetown University and an MS from Youngstown State University.
David Cullin, Ph.D., Vice Chair
Cullin Consulting After 18 years working in various roles in commercial industry and almost 15 as a US DOD Civilian, Dr. Cullin formed Cullin Consulting, LLC to provide strategic business growth and technology commercialization consulting services to his clients. Prior to this, Dave served as Vice President of Technology and Product Management for Teledyne FLIR Defense. In this role, he led a team focused on product innovation, commercialization and developing transformative customer solutions to grow Teledyne’s market position. Dave served in many capacities within the Teledyne FLIR Defense organization. He was General Manager of the Teledyne FLIR Defense Unmanned and Integrated Solutions business, overseeing a broad portfolio of unmanned aerial and ground systems. He served as General Manager of Teledyne FLIR’s Detection business, comprising a wide range of Chemical, Biological, Radiological, Nuclear and Explosive (CBRNE) sensors, as well as systems integration capability, all mainly serving the global defense and security markets. Before Teledyne Technologies acquired FLIR Systems in 2021, Dave was General Manager of FLIR’s CBRNE business unit, where he developed and brought to market a suite of CBRNE sensors and integrated systems. Earlier, Dave was Chief Technology Officer of FLIR Government Systems after they acquired ICx Technologies, which he had joined in 2005. Before moving to the private sector, Dave enjoyed a successful 15-year career with the U.S. Department of Defense, starting in 1991 as a Research Chemist with the Naval Surface Warfare Center. In 1996, he assumed duties as NSWCDD Project Manager of the Portal Shield Advanced Concept Technology Demonstration Program, supporting the Joint Program Office for Biological Defense (JPO-BD). In 1998, Dave was named Director of JPO-BD’s Critical Reagents Program, where he managed procurement and fielding for all of DoD’s reagent-based consumables as well as a robust research and development effort. From 2003 until 2005, he served as Director of Technology at the Joint Program Executive Office for Chemical and Biological Defense and was focused on transitioning new technologies into advanced development and procurement programs. Dave earned a Bachelor of Science degree in Chemistry from the University of Pittsburgh-Johnstown, and his master’s and doctorate degrees in Physical Chemistry from The Ohio State University.
John Wheeler, Treasuer
BIG, LLC John Wheeler has been involved in the CBRNE industry supporting the Edgewood Chemical Biological Center (ECBC) and Joint Program Executive Office (JPEO) for over 25 years. He has overseen numerous contracts that resulted in the successful delivery of over $1B of services and products throughout the world in support of national defense. In 2005, John co-founded Veteran Corps of America (VCA) intending to hire military veterans and their families to support CBRNE and technology requirements. VCA’s motto, “We Are Veteran Enabled!” reflects a family legacy of military service that includes General Earl G. Wheeler, 46-year Army veteran and longest-serving Chairman of the Joint Chiefs (1964-1970). In 2013, John was awarded the Order of the Dragon by the Chemical Corps Regimental Association for his ongoing patronage and support. Prior to being acquired by INTERFUZE Corporation in 2017, VCA provided over $1M to numerous veteran charities and support events and was named to the Inc 500 four times, including #30. In 2020, John left VCA to form Bullock Island Group (www.goBIG.llc) to support strategic relationship development, public policy, and natural resources conservation. In addition, he is President of the Jefferson Islands Club (www.theJIC.org), a 501c non-profit formed in 1931 whose mission is to support bipartisanship and compromise in Government leadership. He earned a bachelor’s degree in Economics from the University of Virginia and resides in Clifton, Virginia with his wife Jennifer.
Directors
Carolanne O'Neil, Executive Director
CAO Carolanne O’Neil is the owner of CAO, a woman-owned small business specializing in CBRN consulting and award-winning creative design. A graduate of the College of Arts + Architecture Graphic Design program at Penn State University, Carolanne brings over 20 years of experience in branding, identity systems, invitations, retail and corporate marketing, publication design, and event management.
Previously, she served as Vice President of Marketing for Domenix, contributing to innovative solutions supporting defense and national security. Earlier in her career, Carolanne joined Veteran Corps — now Interfuze — where she expanded her focus into the defense sector full time, supporting critical missions through marketing, branding, and strategic communication efforts.​ Carolanne has been an active member of the CBRNE Industry Group for the past 14 years, proudly promoting the group through her design and management of the CBRNE Industry Group event engagement and promotional initiatives. Through CAO, based in the Washington, D.C. metro area, she focuses on delivering brand strategy, marketing, and high-impact visual communications that help organizations enhance acquisition pull, stakeholder engagement, and mission success.​ She excels at translating complex technical topics into accessible, engaging narratives and materials, partnering with government agencies and industry leaders to elevate visibility, influence, and market presence. Carolanne is also a member of CLONE: CBRNE Ladies Only Network, and actively supports the Chemical Corps Regimental Association, managing golf events that help raise significant donations for the Corps and foster community engagement with soldiers. Her work has earned recognition for excellence in design, innovation, and event execution across diverse CBRN initiatives.
Hexagon US Federal Neil A. Cohen has served on the CBRNE Industry Group board in different capacities since 2009 and has led new membership recruitment as well as current member outreach. Neil has been actively involved in the CBRNe GovCon space since 2002. Neil serves as Executive Account Manager, All Hazards-Emerging Threats for Hexagon US Federal, the US-based IT provider and system integrator for all Hexagon AB technology, including PNT, C4ISR, Geospatial Intelligence, Public Safety, Digital Twins, and more. Neil has over 30 years’ experience in sales, marketing, and business development, has earned his B.A. from The College of New Jersey in 1989 and his M.B.A. from Marymount University in 2000. Neil also has written four published fiction and non-fiction books. He is married with two daughters.
COL Christopher Grice, USA, Ret. Director
ARServices | Precision Collective COL Christopher Grice, USA, Ret. Christopher Grice is a strategic leader and subject matter expert in program management for chemical, biological, radiological, nuclear, and explosive (CBRNE) science and technology, with over 30 years of experience in the defense industry. I currently serve as the Project Management Task Lead for ARS Limited within the Research and Development Directorate of the Defense Threat Reduction Agency (DTRA), where I lead a team of professional acquisition and advisory assistance (A&AS) personnel. Together, we manage a diverse and highimpact portfolio of research and development programs that deliver innovative solutions to counter and deter weapons of mass destruction (WMD) and improvised threats. In this role, I drive collaboration across key stakeholders—including the Joint Staff, the Services, Combatant Commands, national laboratories, and multiple DTRA directorates—to ensure alignment, efficiency, and mission success. I bring deep expertise in the Planning, Programming, Budgeting, and Execution (PPBE) process, as well as in HAZMAT, CBRNE, and emergency management. My work supports senior leaders and decisionmakers as they navigate some of the most complex and urgent challenges in national security. I strive to advance the development and deployment of cuttingedge capabilities that protect the United States and its allies from both current and emerging threats. COL Christopher Grice assumed the position of Acting Director for the Joint Science and Technology Office (JSTO) in August 2022. A native of Galesburg, Illinois, COL Grice enlisted in the Army National Guard in 1989. He earned a Biological Sciences Degree from Southern Illinois University and a commission as a Chemical Officer in 1995. His last assignment was as the Director of Materiel for the Office of the Deputy Chief of Staff, Headquarters Department of the Army (HQDA) G8 from June 2020 to July 2022. COL Grice earned a Master of Science Degree in Environmental Management from Webster University in 2006 and a Master of Science Degree in Joint Campaign Planning and Strategy from the National Defense University (Joint Advanced Warfighting School) in 2015. COL Grice commanded the 69th Chemical Company in Hanau, Germany from 20012003, the Blue Grass Chemical Activity at Blue Grass Army Depot, Kentucky from 20122014, and the Pueblo Chemical Depot in Pueblo, Colorado from 20172019. Key assignments include Instructor and Chief of Officer Training at the CBRN School from 2003 to 2005. Battalion Executive Officer and Operations Officer (S3) for 110th Chemical Battalion (Technical Escort) at Joint Base Lewis McCord, Washington from 2007 to 2009. Executive Assistant to the Director of the Joint Staff and Counterproliferation Branch Chief for the Joint Staff 2009 to 2011. Senior Strategic Planner, U.S. Plans for United States Forces Korea from 20152017. He was then assigned to the HQDA ODCS G8 as the Division Chief for the Full Dimension Protection division from July 2019 to June 2020. Operational and Support deployments include Operation Joint Guardian in Kosovo as part of Task Force Falcon while the CBRN Officer for 2nd Brigade, 1st Armored Division and Operation Iraqi Freedom as the company commander of the 69th Chemical Company. His awards and decorations include the Legion of Merit (with OLC), Bronze Star Medal, Defense Meritorious Service Medal (with OLC), Meritorious Service Medal (with OLC), Army Commendation Medal (with OLC), Army Achievement Medal (with OLC), Joint Meritorious Unit Award, Army Reserve Component Achievement Medal, Kosovo Campaign Medal, Iraq Campaign Medal, Global War on Terrorism Service Medal, Korean Service Medal, Humanitarian Service Medal, NCO Professional Development Ribbon, Army Service Ribbon, Overseas Service Ribbon (Numeral 2), NATO Medal, Joint Chiefs of Staff Identification Badge, Army Staff Identification Badge, and the Senior Parachutist Badge. His foreign awards include the German Armed Forces Efficiency Badge.
Advocate Health The Regenerative Medicine Hub continues to grow and attract top talent with the addition of Ron Hann, PhD, a former senior level official with the Department of Defense. As Director for Technology Integration, he will be working with the RegenMed Development Organization (ReMDO), one of the driving forces behind the RegenMed Hub and its RegeneratOR programs, as well as its collaborative research partner, the Wake Forest Institute for Regenerative Medicine (WFIRM). Hann’s areas of focus includes national and government business development. Formerly, Hann was a member of the Senior Executive Service (SES), in the Department of Defense (DoD), serving as the Acting Director, Research and Development Directorate for the Defense Threat Reduction Agency (DTRA), located on Fort Belvoir, VA. In that role, he supported DTRA’s mission to enable the DoD and U.S. Government to prepare for and combat weapons of mass destruction and emerging threats and to ensure nuclear deterrence. From 2014-2020, he served as Director of the Chemical and Biological Technologies Department, which addressed the threats posed by chemical and biological weapons. He also served as Director for the Joint Science and Technology Office, a component of the Chemical and Biological Defense Program, which was established by Congress in 2003 and tasked to coordinate, integrate, execute, and transition DoD chemical and biological science and technology medical and nonmedical programs. “WFIRM and its collaborating research partner, ReMDO, have a long history of DoD research funded programs to develop regenerative medicine therapies for wounded warriors,” said WFIRM Director Anthony Atala, MD. “The addition of Hann and his wealth of experience in military leadership positions and commercial product translation is invaluable.” Gary Green, EdD, Chief Operating Officer for ReMDO, said Hann would play a valuable role in the mission of the RegenMed Hub -- to bring together resources and partnerships. “Dr. Hann will be instrumental in helping us continue to build and expand the regenerative medicine ecosystem.” The RegenMed Hub is the one of the fastest growing intersections of biotechnology innovation and business in the nation and is centered in and around the Innovation Quarter district in Winston-Salem, NC, which is focused on research, biomedical science education, and business. For Hann, moving on from the DoD, but remaining involved in research efforts through WFIRM and the RegenMed Development Organization (ReMDO), was a good fit. “The opportunity to be a part of these organizations and help support the advancement of regenerative medicine technologies is exciting,” he said.- “As a combat veteran, it is important to me that our warfighters get the best healthcare possible, especially when they are wounded in action. I like to tell my friends there is still a lot of camouflage covering my heart. Regenerative medicine has been at the forefront of improving the quality of life of our wounded veterans for decades and I see a spectacular future ahead in this scientific discipline.” Hann retired from the U.S. Army Chemical Corps in 2014, following nearly 27 years of active-duty service. Assignments included command and staff positions at all levels within the Army. Academically, Hann served two tours as an Assistant Professor of Chemistry and Researcher at the U.S. Military Academy at West Point. While there, he professionally developed the Army’s next generation of future leaders. He is a decorated combat veteran of Operation Desert Shield/Desert Storm and Operation Iraqi Freedom. He also served in the NATO peacekeeping mission in Bosnia-Herzegovina as part of Operation Joint Forge. Hann holds bachelors and master’s degrees in chemistry from the College of William and Mary and a doctorate in organic synthesis from the University of Virginia.
Gregory Mogilevsky, PhD, PMP Director
Battelle Dr. Gregory Mogilevsky is the Director of CBRNE Business Development at Battelle, where he leads strategic growth and opportunity shaping across CBRNE, DoD, and Civil markets. His career is distinguished by over 15 years of advancement within the Government RDT&E ecosystem, beginning as a National Research Council Postdoctoral Associate at the Edgewood Chemical Biological Center (ECBC). This foundational experience in the lab—developing next-generation filtration and decontamination materials—evolved into senior scientific and program management leadership roles at Booz Allen Hamilton, Leidos, and Systems Planning and Analysis (SPA). By transitioning from a lead research scientist to a systems engineer and, ultimately, a business development executive, Dr. Mogilevsky has developed a rare, 360-degree view of the acquisition lifecycle. A PMP-certified leader with a PhD in Materials Science, he excels at bridging the gap between emerging technical innovation and mission-critical requirements. He is a recognized expert in positioning organizations at the forefront of national security R&D, with a proven track record of translating complex scientific advancements into actionable growth and long-term value for the warfighter.
Mike Stebbins, Ph.D., Director
ATI MIKE STEBBINS, Ph.D is the Executive Director for the Countering Weapons of Mass Destruction (CWMD) Consortium. The CWMD is an enterprise partnership between the US Government (DoD, JPEO-CBRND) and the CWMD Consortium connected through a “contract-like” Other Transaction Agreement (OTA). This OTA operates outside the Federal Acquisition Regulations and targets prototype development to understand, detect, counter and ultimately defeat exposure to weapons of mass destruction. The CWMD Consortium has nearly 400 entities comprised of industry, academia and non-profits that all have expertise in aspects of counter WMD technologies. The usage of an OTA allows government to partner with the CWMD to leverage cutting-edge R&D and develop prototypes. This gives government agencies an agile and flexible way to develop CWMD prototypes using new and innovative technology. The CWMD provides the flexibility for better public and private collaboration by providing access to innovative concepts, ideas, and technologies from traditional and non-traditional technology providers. Through the OTA with the CWMD Consortium, the JPEO-CBRND and other government customers are looking to work with new industry partners to provide soldiers with safe and effective weapons of mass destruction countermeasures. To date, the CWMD Consortium and OTA have awarded 165 unique prototyping projects valued in excess of $1B. The CWMD government customer base includes JPEO-CBRND, DTRA, PEO ACWA, DHS CWMD Office, DEVCOM CBC and others. Dr. Stebbins also serves as the Executive Director for the Medical CBRN Defense Consortium (MCDC), also aligned with the JPEO and their CBRN Medical Group. The MCDC and associated OTA work in a similar manner to that of the CWMD and address the development of prototypes that diagnose, treat or prevent CBRN exposure by DoD’s warfighters. The MCDC has just over 300 members and has awarded 78 unique prototype projects valued at $8B. Dr. Stebbins has been with the MCDC (2016) and CWMD (2017) since inception and has a 15-year history with ATI (the Consortium Management Firm), managing numerous FAR and OTA-based programs as well as business development. He holds a B.S. in Chemistry from the College of Charleston and a Ph.D. in Analytical Chemistry from the University of Tennessee-Knoxville.
Chair Emeritus
Year Chair Organization When Chair
1996-1997 Bill Richardson Bill Richardson Consulting
1997-1998 Marilyn Ripin JAYCOR
1998-1999 Manuel Sanches System Planning Corp
1999-2000 John Carrico SRI International
2000-2001 Sam Ankerbrandt Braddock Smith Group
2001-2002 Amoretta M. Hoeber AMH Consulting
2002-2003 James F. Horton Horton Consulting
2003-2004 Arlene Selber GEO-CENTERS, INC.
2004-2005 John Wade Battelle Memorial Institute
2005-2006 Allan Cameron CSC
2006-2007 Bruce Dobbs Washington Group International
2007-2008 Virginia Morlock Northrop Grumman
2008-2009 James T. Ferguson, Sr. Technology Marketing
2009-2010 Lynn Henselman Capitol Consulting Group, LLC
2010-2011 Chris Parker Northrop Grumman
2011-2012 Eric Reid SAIC
2012-2013 Mandy Lopez Tex-Shield, Inc.
2013-2014 Bill Baugh Bill Baugh Associates
2014-2015 Rebecca Robertson INFICON, Inc.
2015-2016 Virginia Morlock Northrop Grumman
2016-2017 Justin Haynes Gore® Creative Technologies Worldwide
2017-2018 Pat Sharon LMI
2018-2019 Charles Janney Veteran Corps – An INTERFUZE Company
2019-2020 Scott Robinson Battelle
2020-2022 William King Booz | Allen | Hamilton
2022-2024 Ron Fizer ARServices
2024-2026 Kim Chamblin Boston Dynamics
Meet Our Dynamic Industry Partners! Contact us.
We are here to assist. Contact us by phone, email or via our Social Media channels.